Patent · US Active

Uses of orvepitant

US9603849B2 · kind B2 · utility

3Cited by

3References

5Claims

0Family size

Assignee

NeRRe Therapeutics Limited · GB

Inventors

Emiliangelo Ratti · Verona, IT
Michael Trower · Cambridge, GB

Key dates

Filing date	Oct 9, 2013
Grant date	Mar 28, 2017
Priority date	—
Expiry date	Oct 9, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P17/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to the new use of the compound (I) or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing it for the treatment of pruritus and to combinations for such a use.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.